Background Results

AcknowledgmentsConclusionDiscussion

Methods

In vitro and in vivo metabolite profiling and identification of edasalonexent (CAT-1004), a bioconjugate of salicylic acid (SA) and docosahexaenoic acid (DHA) using SMART linker technology

Liu H1, Ting A1, Lee D1, Zimmer M1, Wachtel D1, Dagher R1, Mancini M1, Donovan J1, Liu F1, Greene R2, Keehn R2, Cardinal K2,Luo G2, Erratico C-A3, Fonsi M3, and Nichols A1

1Catabasis Pharmaceuticals, Inc., Cambridge, MA, USA, 2Covance Laboratories Inc., Madison, WI, USA, 3CiTox Lab, Evreux Cedex, France